VGKC antibody have been detected in peripheral nervous system disease specifically associated with the clinical spectrum of Acquired neuromyotonia (NMT) and Cramp-fasciculation syndrome (CFS), and disorders of the central nervous system, including Morvan syndrome, Epilepsy and Limbic encephalitis (LE).